|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
REACTINT VIOLET X80LT
|
413-380-1
|
-
|
|
|
|
|
UM-228
|
406-390-2
|
-
|
|
|
|
|
DTBA
|
401-980-6
|
-
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
-
|
-
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
|
|
-
|
-
|
|
|
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
|
|
|
-
|
-
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
-
|
-
|
|
|
B Bacteria and similar species
|
|
|
931-755-2
|
-
|
|
|
|
|
|
931-756-8
|
-
|
|
|
|
|
|
931-753-1
|
-
|
|
|
|
|
|
931-754-7
|
-
|
|
|
|
|
|
939-993-9
|
-
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
938-618-6
|
-
|
|
|
|
|
|
932-998-7
|
-
|
|
|
|
|
|
-
|
-
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
|
|
-
|
-
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
|
|
-
|
-
|
|
|
|
|
|
-
|
-
|
|
|
|
|
H112339
|
413-550-5
|
-
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
700-960-7
|
-
|
|
|
|
|
|
-
|
-
|
|
|
|
C1B Carcinogenic, Category 1B.
|
|
-
|
-
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
|
|
-
|
-
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|